AGP Picks
View all

STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on July 7, 2026

CommLab India Ranks #2 Among the Top eLearning Companies for Simulation Training
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
CPI Aero Secures $8.3 Million in New U.S. Air Force Orders for T-38 Aircraft Modification Kits
Axe Compute Inc. Joins Russell Microcap® Index, Reflecting Its Growth as a Publicly Traded AI Infrastructure Platform
Snail Games Launches ARK: Genesis Part 1 Ascended, ARK Tides of Fortune, and ARK: Dragontopia DLC; $11 Million from Deferred Revenue Backlog to be Recognized in Q3 2026
Duos Signs Agreement for an Additional 2 MW Deployment
Trust Stamp joins the European Union Semiconductor Initiative (IPCEI AST) with the Support of Malta Enterprise
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
House of Doge Issues Mid-2026 Shareholder Letter Highlighting Achievements after Merger and Becoming a Nasdaq-Listed Platform
Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling
Core AI Holdings Appoints Arie Goor as Chief Financial Officer
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
Scality and WEKA deepen partnership to accelerate enterprise AI adoption
Pasqal and MegazoneCloud Partner to Bring Industrial-Scale Quantum Computing to South Korea
Nu-Tek BioSciences Present Cell Nutrient Innovation, Raw Material Expertise at SIMB 2026
Nu-Tek BioSciences präsentiert auf der SIMB 2026 Innovationen im Bereich Zellnährstoffe und sein Fachwissen zu Rohstoffen
Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
CoRegen, Inc. Receives FDA Clearance to Advance CRG-150 into Phase 1/2a Clinical Trials, Pioneering a New Frontier in Cell Therapy for Multiple Solid Tumor Types

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM Minnesota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.